Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 1/2022

01-01-2022 | Computed Tomography | Original Article

Lymph node metastasis and predictive factors in clinical stage IA squamous cell carcinoma of the lung based on radiological findings

Authors: Kenta Tane, Tomohiro Miyoshi, Joji Samejima, Keiju Aokage, Genichiro Ishii, Masahiro Tsuboi

Published in: General Thoracic and Cardiovascular Surgery | Issue 1/2022

Login to get access

Abstract

Objectives

We aimed to clarify the incidence of lymph node (LN) metastasis and its predictive factors in clinical stage IA squamous cell carcinoma (SqCC) based on radiological classification to provide surgical indications for segmentectomy.

Methods

We retrospectively reviewed 192 patients with clinical stage IA SqCC who underwent complete resection with lobectomy and LN dissection at our institution between 2003 and 2019. To evaluate the incidence of LN metastasis from the perspective of indications for segmentectomy, we classified them into outer and inner groups based on the location of the tumor in the radiological findings.

Results

Regarding tumor location, 123 patients had tumors in the outer location and 69 patients had tumors in the inner location. The incidence of LN metastasis was 6% in clinical stage IA SqCC, which included 6% in the outer location and 7% in the inner location (p = 0.669). In the outer location, all LN metastases were in N1 (6%); whereas in the inner location, the incidence of N1 and N2 metastasis were 6% and 1%, respectively. Only tumors sized > 2.0 cm were found to be significantly associated with LN metastasis in clinical stage IA SqCC.

Conclusions

We demonstrated that the incidence of LN metastasis in clinical stage IA SqCC was comparable to that of the previously reported clinical stage IA NSCLC. The incidence of LN metastasis in the outer location was similar to that in the inner location. Tumor size was only a significant factor affecting LN metastasis in clinical stage IA SqCC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sakairi Y, Wada H, Fujiwara T, Suzuki H, Nakajima T, Chiyo M, et al. The probability of nodal metastasis in novel T-factor: the applicability of sublobar resection. J Thorac Dis. 2019;11:4197–204.CrossRef Sakairi Y, Wada H, Fujiwara T, Suzuki H, Nakajima T, Chiyo M, et al. The probability of nodal metastasis in novel T-factor: the applicability of sublobar resection. J Thorac Dis. 2019;11:4197–204.CrossRef
2.
go back to reference Deng HY, Zhou J, Wang RL, Jiang R, Qiu XM, Zhu DX, et al. Surgical choice for clinical stage IA non-small cell lung cancer: view from regional lymph node metastasis. Ann Thorac Surg. 2020;109:1079–85.CrossRef Deng HY, Zhou J, Wang RL, Jiang R, Qiu XM, Zhu DX, et al. Surgical choice for clinical stage IA non-small cell lung cancer: view from regional lymph node metastasis. Ann Thorac Surg. 2020;109:1079–85.CrossRef
3.
go back to reference Wang L, Jiang W, Zhan C, Shi Y, Zhang Y, Lin Z, et al. Lymph node metastasis in clinical stage IA peripheral lung cancer. Lung Cancer. 2015;90:41–6.CrossRef Wang L, Jiang W, Zhan C, Shi Y, Zhang Y, Lin Z, et al. Lymph node metastasis in clinical stage IA peripheral lung cancer. Lung Cancer. 2015;90:41–6.CrossRef
4.
go back to reference Tsutani Y, Murakami S, Miyata Y, Nakayama H, Yoshimura M, Okada M. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung. Eur J Cardiothorac Surg. 2015;47:1022–6.CrossRef Tsutani Y, Murakami S, Miyata Y, Nakayama H, Yoshimura M, Okada M. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung. Eur J Cardiothorac Surg. 2015;47:1022–6.CrossRef
5.
go back to reference Fuwa N, Mitsudomi T, Daimon T, Yatabe Y, Shinoda M, Hatooka S, et al. Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer—from studies of 604 surgical cases. Lung Cancer. 2007;57:311–6.CrossRef Fuwa N, Mitsudomi T, Daimon T, Yatabe Y, Shinoda M, Hatooka S, et al. Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer—from studies of 604 surgical cases. Lung Cancer. 2007;57:311–6.CrossRef
6.
go back to reference Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158:895–907.CrossRef Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158:895–907.CrossRef
7.
go back to reference Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRef Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRef
8.
go back to reference . WHO Classification of tumours of the lung, pleura, thymus and hearted. International Agency for Research on Cancer, 2015. . WHO Classification of tumours of the lung, pleura, thymus and hearted. International Agency for Research on Cancer, 2015.
9.
go back to reference Berry MF, Gao R, Kunder CA, Backhus L, Khuong A, Kadoch M, et al. Presence of even a small ground-glass component in lung adenocarcinoma predicts better survival. Clin Lung Cancer. 2018;19:e47–51.CrossRef Berry MF, Gao R, Kunder CA, Backhus L, Khuong A, Kadoch M, et al. Presence of even a small ground-glass component in lung adenocarcinoma predicts better survival. Clin Lung Cancer. 2018;19:e47–51.CrossRef
10.
go back to reference Ye B, Cheng M, Li W, Ge XX, Geng JF, Feng J, et al. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann Thorac Surg. 2014;98:217–23.CrossRef Ye B, Cheng M, Li W, Ge XX, Geng JF, Feng J, et al. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann Thorac Surg. 2014;98:217–23.CrossRef
11.
go back to reference Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg. 2012;144:1365–71.CrossRef Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg. 2012;144:1365–71.CrossRef
12.
go back to reference Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R, et al. The influence of clinical T factor on predicting pathologic N factor in resected lung cancer. Ann Thorac Surg. 2019;108:1080–6.CrossRef Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R, et al. The influence of clinical T factor on predicting pathologic N factor in resected lung cancer. Ann Thorac Surg. 2019;108:1080–6.CrossRef
13.
go back to reference Koike T, Kitahara A, Sato S, Hashimoto T, Aoki T, Koike T, et al. Lobectomy versus segmentectomy in radiologically pure solid small-sized non-small cell lung cancer. Ann Thorac Surg. 2016;101:1354–60.CrossRef Koike T, Kitahara A, Sato S, Hashimoto T, Aoki T, Koike T, et al. Lobectomy versus segmentectomy in radiologically pure solid small-sized non-small cell lung cancer. Ann Thorac Surg. 2016;101:1354–60.CrossRef
14.
go back to reference Inoue M, Minami M, Sawabata N, Utsumi T, Kadota Y, Shigemura N, et al. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiothorac Surg. 2010;37:1445–9.CrossRef Inoue M, Minami M, Sawabata N, Utsumi T, Kadota Y, Shigemura N, et al. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiothorac Surg. 2010;37:1445–9.CrossRef
15.
go back to reference Winckelmans T, Decaluwe H, De Leyn P, Van Raemdonck D. Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2020;57:1051–60.CrossRef Winckelmans T, Decaluwe H, De Leyn P, Van Raemdonck D. Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2020;57:1051–60.CrossRef
16.
go back to reference Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125–34.CrossRef Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125–34.CrossRef
17.
go back to reference Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardio Thorac Surg. 2001;20:1007–11.CrossRef Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardio Thorac Surg. 2001;20:1007–11.CrossRef
18.
go back to reference Gomez-Caro A, Boada M, Cabanas M, Sanchez M, Arguis P, Lomena F, et al. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Eur J Cardiothorac Surg. 2012;42:93–100 (discussion).CrossRef Gomez-Caro A, Boada M, Cabanas M, Sanchez M, Arguis P, Lomena F, et al. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Eur J Cardiothorac Surg. 2012;42:93–100 (discussion).CrossRef
19.
go back to reference Bille A, Woo KM, Ahmad U, Rizk NP, Jones DR. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients. Eur J Cardiothorac Surg. 2017;51:674–9.CrossRef Bille A, Woo KM, Ahmad U, Rizk NP, Jones DR. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients. Eur J Cardiothorac Surg. 2017;51:674–9.CrossRef
Metadata
Title
Lymph node metastasis and predictive factors in clinical stage IA squamous cell carcinoma of the lung based on radiological findings
Authors
Kenta Tane
Tomohiro Miyoshi
Joji Samejima
Keiju Aokage
Genichiro Ishii
Masahiro Tsuboi
Publication date
01-01-2022
Publisher
Springer Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 1/2022
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-021-01681-7

Other articles of this Issue 1/2022

General Thoracic and Cardiovascular Surgery 1/2022 Go to the issue